ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Citalopram Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-25F1792
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Citalopram Market Insights and Forecast to 2028
BUY CHAPTERS

Global Citalopram Market Research Report 2025

Code: QYRE-Auto-25F1792
Report
September 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
H Lundbeck A S
Amneal Pharmaceuticals
Aurobindo Pharma
Hetero Drugs
Macleods Pharmaceuticals
Silarx Pharmacueticals
Apotex
Hikma Pharmaceuticals
Jubilant Pharma
Lupin Ltd
Prinston Pharmaceutical
STI Pharma
Teva Pharmaceutical
Hexal
Shanghai Great Wall Pharmaceutical
Wanquan Wante Pharmaceutical
Northeast Pharmaceutical Group
Sichuan Kelun Pharmaceutical
Kunming Jida Pharmaceutical
Jiangsu Enhua Pharmaceutical
Southwest Pharmaceutical

Citalopram Market

The global market for Citalopram was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Citalopram is a selective serotonin reuptake inhibitor (SSRI), a racemate.It can selectively inhibit the 5-ht transporter, block the reuptake of 5-ht by the presynaptic membrane, prolong and increase the effect of 5-ht, and thus produce antidepressant effect.
North American market for Citalopram is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Citalopram is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Citalopram in Depression is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Citalopram include H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, Silarx Pharmacueticals, Apotex, Hikma Pharmaceuticals, Jubilant Pharma, Lupin Limited, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Citalopram, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Citalopram.
The Citalopram market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Citalopram market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Citalopram companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Citalopram Market Report

Report Metric Details
Report Name Citalopram Market
Segment by Type
  • Solution
  • Tablets
  • Other
Segment by Application
  • Depression
  • Generalized Anxiety
  • Obsessive Compulsive Disorder
  • Somatoform Disorder
  • Schizophrenia
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, Silarx Pharmacueticals, Apotex, Hikma Pharmaceuticals, Jubilant Pharma, Lupin Limited, Prinston Pharmaceutical, STI Pharma, TEVA Pharmaceutical, Hexal, Shanghai Great Wall Pharmaceutical, Wanquan Wante Pharmaceutical, Northeast Pharmaceutical Group, Sichuan Kelun Pharmaceutical, Kunming Jida Pharmaceutical, Jiangsu Enhua Pharmaceutical, Southwest Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Citalopram company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Citalopram Market report?

Ans: The main players in the Citalopram Market are H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, Silarx Pharmacueticals, Apotex, Hikma Pharmaceuticals, Jubilant Pharma, Lupin Limited, Prinston Pharmaceutical, STI Pharma, TEVA Pharmaceutical, Hexal, Shanghai Great Wall Pharmaceutical, Wanquan Wante Pharmaceutical, Northeast Pharmaceutical Group, Sichuan Kelun Pharmaceutical, Kunming Jida Pharmaceutical, Jiangsu Enhua Pharmaceutical, Southwest Pharmaceutical

What are the Application segmentation covered in the Citalopram Market report?

Ans: The Applications covered in the Citalopram Market report are Depression, Generalized Anxiety, Obsessive Compulsive Disorder, Somatoform Disorder, Schizophrenia, Other

What are the Type segmentation covered in the Citalopram Market report?

Ans: The Types covered in the Citalopram Market report are Solution, Tablets, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Citalopram Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solution
1.2.3 Tablets
1.2.4 Other
1.3 Market by Application
1.3.1 Global Citalopram Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Depression
1.3.3 Generalized Anxiety
1.3.4 Obsessive Compulsive Disorder
1.3.5 Somatoform Disorder
1.3.6 Schizophrenia
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Citalopram Market Perspective (2020-2031)
2.2 Global Citalopram Growth Trends by Region
2.2.1 Global Citalopram Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Citalopram Historic Market Size by Region (2020-2025)
2.2.3 Citalopram Forecasted Market Size by Region (2026-2031)
2.3 Citalopram Market Dynamics
2.3.1 Citalopram Industry Trends
2.3.2 Citalopram Market Drivers
2.3.3 Citalopram Market Challenges
2.3.4 Citalopram Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Citalopram Players by Revenue
3.1.1 Global Top Citalopram Players by Revenue (2020-2025)
3.1.2 Global Citalopram Revenue Market Share by Players (2020-2025)
3.2 Global Citalopram Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Citalopram Revenue
3.4 Global Citalopram Market Concentration Ratio
3.4.1 Global Citalopram Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Citalopram Revenue in 2024
3.5 Global Key Players of Citalopram Head office and Area Served
3.6 Global Key Players of Citalopram, Product and Application
3.7 Global Key Players of Citalopram, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Citalopram Breakdown Data by Type
4.1 Global Citalopram Historic Market Size by Type (2020-2025)
4.2 Global Citalopram Forecasted Market Size by Type (2026-2031)
5 Citalopram Breakdown Data by Application
5.1 Global Citalopram Historic Market Size by Application (2020-2025)
5.2 Global Citalopram Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Citalopram Market Size (2020-2031)
6.2 North America Citalopram Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Citalopram Market Size by Country (2020-2025)
6.4 North America Citalopram Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Citalopram Market Size (2020-2031)
7.2 Europe Citalopram Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Citalopram Market Size by Country (2020-2025)
7.4 Europe Citalopram Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Citalopram Market Size (2020-2031)
8.2 Asia-Pacific Citalopram Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Citalopram Market Size by Region (2020-2025)
8.4 Asia-Pacific Citalopram Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Citalopram Market Size (2020-2031)
9.2 Latin America Citalopram Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Citalopram Market Size by Country (2020-2025)
9.4 Latin America Citalopram Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Citalopram Market Size (2020-2031)
10.2 Middle East & Africa Citalopram Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Citalopram Market Size by Country (2020-2025)
10.4 Middle East & Africa Citalopram Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 H.Lundbeck A/S
11.1.1 H.Lundbeck A/S Company Details
11.1.2 H.Lundbeck A/S Business Overview
11.1.3 H.Lundbeck A/S Citalopram Introduction
11.1.4 H.Lundbeck A/S Revenue in Citalopram Business (2020-2025)
11.1.5 H.Lundbeck A/S Recent Development
11.2 Amneal Pharmaceuticals
11.2.1 Amneal Pharmaceuticals Company Details
11.2.2 Amneal Pharmaceuticals Business Overview
11.2.3 Amneal Pharmaceuticals Citalopram Introduction
11.2.4 Amneal Pharmaceuticals Revenue in Citalopram Business (2020-2025)
11.2.5 Amneal Pharmaceuticals Recent Development
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Details
11.3.2 Aurobindo Pharma Business Overview
11.3.3 Aurobindo Pharma Citalopram Introduction
11.3.4 Aurobindo Pharma Revenue in Citalopram Business (2020-2025)
11.3.5 Aurobindo Pharma Recent Development
11.4 Hetero Drugs
11.4.1 Hetero Drugs Company Details
11.4.2 Hetero Drugs Business Overview
11.4.3 Hetero Drugs Citalopram Introduction
11.4.4 Hetero Drugs Revenue in Citalopram Business (2020-2025)
11.4.5 Hetero Drugs Recent Development
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Details
11.5.2 Macleods Pharmaceuticals Business Overview
11.5.3 Macleods Pharmaceuticals Citalopram Introduction
11.5.4 Macleods Pharmaceuticals Revenue in Citalopram Business (2020-2025)
11.5.5 Macleods Pharmaceuticals Recent Development
11.6 Silarx Pharmacueticals
11.6.1 Silarx Pharmacueticals Company Details
11.6.2 Silarx Pharmacueticals Business Overview
11.6.3 Silarx Pharmacueticals Citalopram Introduction
11.6.4 Silarx Pharmacueticals Revenue in Citalopram Business (2020-2025)
11.6.5 Silarx Pharmacueticals Recent Development
11.7 Apotex
11.7.1 Apotex Company Details
11.7.2 Apotex Business Overview
11.7.3 Apotex Citalopram Introduction
11.7.4 Apotex Revenue in Citalopram Business (2020-2025)
11.7.5 Apotex Recent Development
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Details
11.8.2 Hikma Pharmaceuticals Business Overview
11.8.3 Hikma Pharmaceuticals Citalopram Introduction
11.8.4 Hikma Pharmaceuticals Revenue in Citalopram Business (2020-2025)
11.8.5 Hikma Pharmaceuticals Recent Development
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Details
11.9.2 Jubilant Pharma Business Overview
11.9.3 Jubilant Pharma Citalopram Introduction
11.9.4 Jubilant Pharma Revenue in Citalopram Business (2020-2025)
11.9.5 Jubilant Pharma Recent Development
11.10 Lupin Limited
11.10.1 Lupin Limited Company Details
11.10.2 Lupin Limited Business Overview
11.10.3 Lupin Limited Citalopram Introduction
11.10.4 Lupin Limited Revenue in Citalopram Business (2020-2025)
11.10.5 Lupin Limited Recent Development
11.11 Prinston Pharmaceutical
11.11.1 Prinston Pharmaceutical Company Details
11.11.2 Prinston Pharmaceutical Business Overview
11.11.3 Prinston Pharmaceutical Citalopram Introduction
11.11.4 Prinston Pharmaceutical Revenue in Citalopram Business (2020-2025)
11.11.5 Prinston Pharmaceutical Recent Development
11.12 STI Pharma
11.12.1 STI Pharma Company Details
11.12.2 STI Pharma Business Overview
11.12.3 STI Pharma Citalopram Introduction
11.12.4 STI Pharma Revenue in Citalopram Business (2020-2025)
11.12.5 STI Pharma Recent Development
11.13 TEVA Pharmaceutical
11.13.1 TEVA Pharmaceutical Company Details
11.13.2 TEVA Pharmaceutical Business Overview
11.13.3 TEVA Pharmaceutical Citalopram Introduction
11.13.4 TEVA Pharmaceutical Revenue in Citalopram Business (2020-2025)
11.13.5 TEVA Pharmaceutical Recent Development
11.14 Hexal
11.14.1 Hexal Company Details
11.14.2 Hexal Business Overview
11.14.3 Hexal Citalopram Introduction
11.14.4 Hexal Revenue in Citalopram Business (2020-2025)
11.14.5 Hexal Recent Development
11.15 Shanghai Great Wall Pharmaceutical
11.15.1 Shanghai Great Wall Pharmaceutical Company Details
11.15.2 Shanghai Great Wall Pharmaceutical Business Overview
11.15.3 Shanghai Great Wall Pharmaceutical Citalopram Introduction
11.15.4 Shanghai Great Wall Pharmaceutical Revenue in Citalopram Business (2020-2025)
11.15.5 Shanghai Great Wall Pharmaceutical Recent Development
11.16 Wanquan Wante Pharmaceutical
11.16.1 Wanquan Wante Pharmaceutical Company Details
11.16.2 Wanquan Wante Pharmaceutical Business Overview
11.16.3 Wanquan Wante Pharmaceutical Citalopram Introduction
11.16.4 Wanquan Wante Pharmaceutical Revenue in Citalopram Business (2020-2025)
11.16.5 Wanquan Wante Pharmaceutical Recent Development
11.17 Northeast Pharmaceutical Group
11.17.1 Northeast Pharmaceutical Group Company Details
11.17.2 Northeast Pharmaceutical Group Business Overview
11.17.3 Northeast Pharmaceutical Group Citalopram Introduction
11.17.4 Northeast Pharmaceutical Group Revenue in Citalopram Business (2020-2025)
11.17.5 Northeast Pharmaceutical Group Recent Development
11.18 Sichuan Kelun Pharmaceutical
11.18.1 Sichuan Kelun Pharmaceutical Company Details
11.18.2 Sichuan Kelun Pharmaceutical Business Overview
11.18.3 Sichuan Kelun Pharmaceutical Citalopram Introduction
11.18.4 Sichuan Kelun Pharmaceutical Revenue in Citalopram Business (2020-2025)
11.18.5 Sichuan Kelun Pharmaceutical Recent Development
11.19 Kunming Jida Pharmaceutical
11.19.1 Kunming Jida Pharmaceutical Company Details
11.19.2 Kunming Jida Pharmaceutical Business Overview
11.19.3 Kunming Jida Pharmaceutical Citalopram Introduction
11.19.4 Kunming Jida Pharmaceutical Revenue in Citalopram Business (2020-2025)
11.19.5 Kunming Jida Pharmaceutical Recent Development
11.20 Jiangsu Enhua Pharmaceutical
11.20.1 Jiangsu Enhua Pharmaceutical Company Details
11.20.2 Jiangsu Enhua Pharmaceutical Business Overview
11.20.3 Jiangsu Enhua Pharmaceutical Citalopram Introduction
11.20.4 Jiangsu Enhua Pharmaceutical Revenue in Citalopram Business (2020-2025)
11.20.5 Jiangsu Enhua Pharmaceutical Recent Development
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Company Details
11.21.2 Southwest Pharmaceutical Business Overview
11.21.3 Southwest Pharmaceutical Citalopram Introduction
11.21.4 Southwest Pharmaceutical Revenue in Citalopram Business (2020-2025)
11.21.5 Southwest Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
H Lundbeck A S
Amneal Pharmaceuticals
Aurobindo Pharma
Hetero Drugs
Macleods Pharmaceuticals
Silarx Pharmacueticals
Apotex
Hikma Pharmaceuticals
Jubilant Pharma
Lupin Ltd
Prinston Pharmaceutical
STI Pharma
Teva Pharmaceutical
Hexal
Shanghai Great Wall Pharmaceutical
Wanquan Wante Pharmaceutical
Northeast Pharmaceutical Group
Sichuan Kelun Pharmaceutical
Kunming Jida Pharmaceutical
Jiangsu Enhua Pharmaceutical
Southwest Pharmaceutical
List of Tables
 Table 1. Global Citalopram Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Solution
 Table 3. Key Players of Tablets
 Table 4. Key Players of Other
 Table 5. Global Citalopram Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Citalopram Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Citalopram Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Citalopram Market Share by Region (2020-2025)
 Table 9. Global Citalopram Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Citalopram Market Share by Region (2026-2031)
 Table 11. Citalopram Market Trends
 Table 12. Citalopram Market Drivers
 Table 13. Citalopram Market Challenges
 Table 14. Citalopram Market Restraints
 Table 15. Global Citalopram Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Citalopram Market Share by Players (2020-2025)
 Table 17. Global Top Citalopram Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Citalopram as of 2024)
 Table 18. Ranking of Global Top Citalopram Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Citalopram Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Citalopram, Headquarters and Area Served
 Table 21. Global Key Players of Citalopram, Product and Application
 Table 22. Global Key Players of Citalopram, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Citalopram Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Citalopram Revenue Market Share by Type (2020-2025)
 Table 26. Global Citalopram Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Citalopram Revenue Market Share by Type (2026-2031)
 Table 28. Global Citalopram Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Citalopram Revenue Market Share by Application (2020-2025)
 Table 30. Global Citalopram Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Citalopram Revenue Market Share by Application (2026-2031)
 Table 32. North America Citalopram Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Citalopram Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Citalopram Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Citalopram Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Citalopram Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Citalopram Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Citalopram Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Citalopram Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Citalopram Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Citalopram Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Citalopram Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Citalopram Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Citalopram Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Citalopram Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Citalopram Market Size by Country (2026-2031) & (US$ Million)
 Table 47. H.Lundbeck A/S Company Details
 Table 48. H.Lundbeck A/S Business Overview
 Table 49. H.Lundbeck A/S Citalopram Product
 Table 50. H.Lundbeck A/S Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 51. H.Lundbeck A/S Recent Development
 Table 52. Amneal Pharmaceuticals Company Details
 Table 53. Amneal Pharmaceuticals Business Overview
 Table 54. Amneal Pharmaceuticals Citalopram Product
 Table 55. Amneal Pharmaceuticals Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 56. Amneal Pharmaceuticals Recent Development
 Table 57. Aurobindo Pharma Company Details
 Table 58. Aurobindo Pharma Business Overview
 Table 59. Aurobindo Pharma Citalopram Product
 Table 60. Aurobindo Pharma Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 61. Aurobindo Pharma Recent Development
 Table 62. Hetero Drugs Company Details
 Table 63. Hetero Drugs Business Overview
 Table 64. Hetero Drugs Citalopram Product
 Table 65. Hetero Drugs Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 66. Hetero Drugs Recent Development
 Table 67. Macleods Pharmaceuticals Company Details
 Table 68. Macleods Pharmaceuticals Business Overview
 Table 69. Macleods Pharmaceuticals Citalopram Product
 Table 70. Macleods Pharmaceuticals Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 71. Macleods Pharmaceuticals Recent Development
 Table 72. Silarx Pharmacueticals Company Details
 Table 73. Silarx Pharmacueticals Business Overview
 Table 74. Silarx Pharmacueticals Citalopram Product
 Table 75. Silarx Pharmacueticals Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 76. Silarx Pharmacueticals Recent Development
 Table 77. Apotex Company Details
 Table 78. Apotex Business Overview
 Table 79. Apotex Citalopram Product
 Table 80. Apotex Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 81. Apotex Recent Development
 Table 82. Hikma Pharmaceuticals Company Details
 Table 83. Hikma Pharmaceuticals Business Overview
 Table 84. Hikma Pharmaceuticals Citalopram Product
 Table 85. Hikma Pharmaceuticals Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 86. Hikma Pharmaceuticals Recent Development
 Table 87. Jubilant Pharma Company Details
 Table 88. Jubilant Pharma Business Overview
 Table 89. Jubilant Pharma Citalopram Product
 Table 90. Jubilant Pharma Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 91. Jubilant Pharma Recent Development
 Table 92. Lupin Limited Company Details
 Table 93. Lupin Limited Business Overview
 Table 94. Lupin Limited Citalopram Product
 Table 95. Lupin Limited Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 96. Lupin Limited Recent Development
 Table 97. Prinston Pharmaceutical Company Details
 Table 98. Prinston Pharmaceutical Business Overview
 Table 99. Prinston Pharmaceutical Citalopram Product
 Table 100. Prinston Pharmaceutical Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 101. Prinston Pharmaceutical Recent Development
 Table 102. STI Pharma Company Details
 Table 103. STI Pharma Business Overview
 Table 104. STI Pharma Citalopram Product
 Table 105. STI Pharma Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 106. STI Pharma Recent Development
 Table 107. TEVA Pharmaceutical Company Details
 Table 108. TEVA Pharmaceutical Business Overview
 Table 109. TEVA Pharmaceutical Citalopram Product
 Table 110. TEVA Pharmaceutical Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 111. TEVA Pharmaceutical Recent Development
 Table 112. Hexal Company Details
 Table 113. Hexal Business Overview
 Table 114. Hexal Citalopram Product
 Table 115. Hexal Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 116. Hexal Recent Development
 Table 117. Shanghai Great Wall Pharmaceutical Company Details
 Table 118. Shanghai Great Wall Pharmaceutical Business Overview
 Table 119. Shanghai Great Wall Pharmaceutical Citalopram Product
 Table 120. Shanghai Great Wall Pharmaceutical Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 121. Shanghai Great Wall Pharmaceutical Recent Development
 Table 122. Wanquan Wante Pharmaceutical Company Details
 Table 123. Wanquan Wante Pharmaceutical Business Overview
 Table 124. Wanquan Wante Pharmaceutical Citalopram Product
 Table 125. Wanquan Wante Pharmaceutical Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 126. Wanquan Wante Pharmaceutical Recent Development
 Table 127. Northeast Pharmaceutical Group Company Details
 Table 128. Northeast Pharmaceutical Group Business Overview
 Table 129. Northeast Pharmaceutical Group Citalopram Product
 Table 130. Northeast Pharmaceutical Group Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 131. Northeast Pharmaceutical Group Recent Development
 Table 132. Sichuan Kelun Pharmaceutical Company Details
 Table 133. Sichuan Kelun Pharmaceutical Business Overview
 Table 134. Sichuan Kelun Pharmaceutical Citalopram Product
 Table 135. Sichuan Kelun Pharmaceutical Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 136. Sichuan Kelun Pharmaceutical Recent Development
 Table 137. Kunming Jida Pharmaceutical Company Details
 Table 138. Kunming Jida Pharmaceutical Business Overview
 Table 139. Kunming Jida Pharmaceutical Citalopram Product
 Table 140. Kunming Jida Pharmaceutical Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 141. Kunming Jida Pharmaceutical Recent Development
 Table 142. Jiangsu Enhua Pharmaceutical Company Details
 Table 143. Jiangsu Enhua Pharmaceutical Business Overview
 Table 144. Jiangsu Enhua Pharmaceutical Citalopram Product
 Table 145. Jiangsu Enhua Pharmaceutical Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 146. Jiangsu Enhua Pharmaceutical Recent Development
 Table 147. Southwest Pharmaceutical Company Details
 Table 148. Southwest Pharmaceutical Business Overview
 Table 149. Southwest Pharmaceutical Citalopram Product
 Table 150. Southwest Pharmaceutical Revenue in Citalopram Business (2020-2025) & (US$ Million)
 Table 151. Southwest Pharmaceutical Recent Development
 Table 152. Research Programs/Design for This Report
 Table 153. Key Data Information from Secondary Sources
 Table 154. Key Data Information from Primary Sources
 Table 155. Authors List of This Report


List of Figures
 Figure 1. Citalopram Picture
 Figure 2. Global Citalopram Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Citalopram Market Share by Type: 2024 VS 2031
 Figure 4. Solution Features
 Figure 5. Tablets Features
 Figure 6. Other Features
 Figure 7. Global Citalopram Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Citalopram Market Share by Application: 2024 VS 2031
 Figure 9. Depression Case Studies
 Figure 10. Generalized Anxiety Case Studies
 Figure 11. Obsessive Compulsive Disorder Case Studies
 Figure 12. Somatoform Disorder Case Studies
 Figure 13. Schizophrenia Case Studies
 Figure 14. Other Case Studies
 Figure 15. Citalopram Report Years Considered
 Figure 16. Global Citalopram Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Citalopram Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Citalopram Market Share by Region: 2024 VS 2031
 Figure 19. Global Citalopram Market Share by Players in 2024
 Figure 20. Global Top Citalopram Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Citalopram as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Citalopram Revenue in 2024
 Figure 22. North America Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Citalopram Market Share by Country (2020-2031)
 Figure 24. United States Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Citalopram Market Share by Country (2020-2031)
 Figure 28. Germany Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Citalopram Market Share by Region (2020-2031)
 Figure 36. China Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Citalopram Market Share by Country (2020-2031)
 Figure 44. Mexico Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Citalopram Market Share by Country (2020-2031)
 Figure 48. Turkey Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Citalopram Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. H.Lundbeck A/S Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 52. Amneal Pharmaceuticals Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 53. Aurobindo Pharma Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 54. Hetero Drugs Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 55. Macleods Pharmaceuticals Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 56. Silarx Pharmacueticals Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 57. Apotex Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 58. Hikma Pharmaceuticals Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 59. Jubilant Pharma Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 60. Lupin Limited Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 61. Prinston Pharmaceutical Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 62. STI Pharma Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 63. TEVA Pharmaceutical Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 64. Hexal Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 65. Shanghai Great Wall Pharmaceutical Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 66. Wanquan Wante Pharmaceutical Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 67. Northeast Pharmaceutical Group Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 68. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 69. Kunming Jida Pharmaceutical Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 70. Jiangsu Enhua Pharmaceutical Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 71. Southwest Pharmaceutical Revenue Growth Rate in Citalopram Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Selective Serotonin Reuptake Inhibitors SSRIs Market Insights Forecast to 2030
Global Selective Serotonin Reuptake Inhibitor Drugs Market Research Report 2024
Global SNRIs Antidepressants Market Research Report 2024
Global NaSSAs Antidepressants Market Research Report 2024
Global Mirtazapine Market Research Report 2024
Global 5 Bromophthalide Market Research Report 2024
Global Sertraline Market Insights Forecast to 2030
Global Vortioxetine Market Research Report 2024
Global Norepinephrine Reuptake Inhibitors Market Research Report 2024
Global Paroxetine Market Insights Forecast to 2030
Global Monoamine Oxidase Inhibitors MAOIs Medications Market Research Report 2024
Global Fluvoxamine Maleate Tablets Market Research Report 2025
Global 5 Hydroxytryptamine Receptor Blocker Market Research Report 2025
Global Atomoxetine HCl API Market Research Report 2024
Depression Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Escitalopram Oxalate API Market Research Report 2025
Global 5 HT Receptor Antagonist Market Research Report 2025
Global Sertraline Hydrochloride Tablet Market Research Report 2024
Anti depressant Drugs Market
Global Amitryptyline Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions